Ng YSE - Search Results

1

Discovery of sterically-hindered phenol compounds with potent cytoprotective activities against ox-LDL-induced retinal pigment epithelial cell death as a potential pharmacotherapy.

Gnanaguru G, Mackey A, Choi EY, Arta A, Rossato FA, Gero TW, Urquhart AJ, Scott DA, D'Amore PA, Ng YSE. Gnanaguru G, et al. Among authors: ng yse. Free Radic Biol Med. 2022 Jan;178:360-368. doi: 10.1016/j.freeradbiomed.2021.11.026. Epub 2021 Nov 27. Free Radic Biol Med. 2022. PMID: 34843917 Free PMC article.

2

[No title available]

[No authors listed] [No authors listed] PMID: 35554480

3

Differential expression of VEGF isoforms in mouse during development and in the adult.

Ng YS, Rohan R, Sunday ME, Demello DE, D'Amore PA. Ng YS, et al. Dev Dyn. 2001 Feb;220(2):112-21. doi: 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1093>3.0.CO;2-D. Dev Dyn. 2001. PMID: 11169844 Free article.

4

The mouse gene for vascular endothelial growth factor. Genomic structure, definition of the transcriptional unit, and characterization of transcriptional and post-transcriptional regulatory sequences.

Shima DT, Kuroki M, Deutsch U, Ng YS, Adamis AP, D'Amore PA. Shima DT, et al. J Biol Chem. 1996 Feb 16;271(7):3877-83. doi: 10.1074/jbc.271.7.3877. J Biol Chem. 1996. PMID: 8632007 Free article.

5

Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188.

Carmeliet P, Ng YS, Nuyens D, Theilmeier G, Brusselmans K, Cornelissen I, Ehler E, Kakkar VV, Stalmans I, Mattot V, Perriard JC, Dewerchin M, Flameng W, Nagy A, Lupu F, Moons L, Collen D, D'Amore PA, Shima DT. Carmeliet P, et al. Nat Med. 1999 May;5(5):495-502. doi: 10.1038/8379. Nat Med. 1999. PMID: 10229225 No abstract available.

6

Endomucin selectively regulates vascular endothelial growth factor receptor-2 endocytosis through its interaction with AP2.

Cano I, Wild M, Gupta U, Chaudhary S, Ng YSE, Saint-Geniez M, D'Amore PA, Hu Z. Cano I, et al. Among authors: ng yse. Cell Commun Signal. 2024 Apr 11;22(1):225. doi: 10.1186/s12964-024-01606-w. Cell Commun Signal. 2024. PMID: 38605348 Free PMC article.

7

Novel engineered, membrane-tethered VEGF-A variants promote formation of filopodia, proliferation, survival, and cord or tube formation by endothelial cells via persistent VEGFR2/ERK signaling and activation of CDC42/ROCK pathways.

Shen J, Rossato FA, Cano I, Ng YSE. Shen J, et al. Among authors: ng yse. FASEB J. 2021 Dec;35(12):e22036. doi: 10.1096/fj.202100448RR. FASEB J. 2021. PMID: 34793603 Free PMC article.

8

Galectin-3 Enhances Vascular Endothelial Growth Factor-A Receptor 2 Activity in the Presence of Vascular Endothelial Growth Factor.

Cano I, Hu Z, AbuSamra DB, Saint-Geniez M, Ng YSE, Argüeso P, D'Amore PA. Cano I, et al. Among authors: ng yse. Front Cell Dev Biol. 2021 Sep 20;9:734346. doi: 10.3389/fcell.2021.734346. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34616740 Free PMC article.

9

Fibrotic Changes and Endothelial-to-Mesenchymal Transition Promoted by VEGFR2 Antagonism Alter the Therapeutic Effects of VEGFA Pathway Blockage in a Mouse Model of Choroidal Neovascularization.

Rossato FA, Su Y, Mackey A, Ng YSE. Rossato FA, et al. Among authors: ng yse. Cells. 2020 Sep 9;9(9):2057. doi: 10.3390/cells9092057. Cells. 2020. PMID: 32917003 Free PMC article.

10

Novel engineered, membrane-localized variants of vascular endothelial growth factor (VEGF) protect retinal ganglion cells: a proof-of-concept study.

Shen J, Xiao R, Bair J, Wang F, Vandenberghe LH, Dartt D, Baranov P, Ng YSE. Shen J, et al. Among authors: ng yse. Cell Death Dis. 2018 Oct 3;9(10):1018. doi: 10.1038/s41419-018-1049-0. Cell Death Dis. 2018. PMID: 30282966 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13 results

Search Page